WFS1 Gene Deafness Autosomal Dominant Type 6 Genetic Test sale cost 4400 AED
DIAPH1 Gene Deafness Autosomal Dominant Type 1 Genetic Test sale cost 4400 AED DIAPH1 Gene Deafness Autosomal Dominant Type 1 Genetic Test 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
RDX Gene Deafness Autosomal Recessive Type 24 Genetic Test sale cost 4400 AED RDX Gene Deafness Autosomal Recessive Type 24 Genetic Test 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

WFS1 Gene Deafness Autosomal Dominant Type 6 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The WFS1 gene, associated with Wolfram syndrome, plays a critical role in the inner ear’s function, impacting hearing capabilities. Mutations in the WFS1 gene can lead to autosomal dominant nonsyndromic hearing loss, specifically classified as Deafness Autosomal Dominant Type 6 (DFNA6). This condition is characterized by progressive, sensorineural hearing loss, primarily affecting the high frequencies.

To diagnose this specific genetic cause of hearing loss, a genetic test targeting the WFS1 gene can be conducted. DNA Labs UAE offers this specialized testing service. The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed for mutations in the WFS1 gene that are known to cause DFNA6.

The cost of the WFS1 Gene Deafness Autosomal Dominant Type 6 Genetic Test at DNA Labs UAE is 4400 AED. This test is crucial for individuals with a family history of hearing loss or those experiencing symptoms of hearing impairment, as it can provide a definitive diagnosis, inform about the progression of the condition, and guide management and treatment options. Additionally, the results can have implications for family planning for those affected or at risk.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

WFS1 Gene Deafness autosomal dominant type 6 Genetic Test

Components: WFS1 Gene Deafness autosomal dominant type 6 Genetic Test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Ear Nose Throat Disorders

Doctor: ENT Doctor

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for PTPN23 Gene Ciliogenesis related disorder NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PTPN23 Gene Ciliogenesis related disorder NGS Genetic DNA Test gene PTPN27

Test Details

The WFS1 gene is associated with a type of deafness known as autosomal dominant type 6 (DFNA6). This type of deafness is inherited in an autosomal dominant pattern, which means that an affected individual has a 50% chance of passing the condition on to each of their children.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that allows for the simultaneous analysis of multiple genes or even the entire genome. In the context of WFS1 gene deafness, NGS genetic testing can be used to identify any mutations or variations in the WFS1 gene that may be causing the deafness.

NGS genetic testing is a powerful tool in genetic diagnosis as it allows for a comprehensive analysis of multiple genes at once, providing a more efficient and cost-effective approach compared to traditional sequencing methods. It can help in confirming a diagnosis, determining the mode of inheritance, and providing information for genetic counseling and family planning.

If an individual suspects they have DFNA6 or a healthcare provider suspects this condition based on symptoms, NGS genetic testing can be ordered to analyze the WFS1 gene and potentially identify any pathogenic variants that may be responsible for the deafness. This information can be valuable in understanding the underlying cause of the condition and guiding appropriate management and treatment options.

Test Name WFS1 Gene Deafness autosomal dominant type 6 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ear Nose Throat Disorders
Doctor ENT Doctor
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for PTPN23 Gene Ciliogenesis related disorder NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PTPN23 Gene Ciliogenesis related disorder NGS Genetic DNA Test gene PTPN27
Test Details

The WFS1 gene is associated with a type of deafness known as autosomal dominant type 6 (DFNA6). This type of deafness is inherited in an autosomal dominant pattern, which means that an affected individual has a 50% chance of passing the condition on to each of their children.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that allows for the simultaneous analysis of multiple genes or even the entire genome. In the context of WFS1 gene deafness, NGS genetic testing can be used to identify any mutations or variations in the WFS1 gene that may be causing the deafness.

NGS genetic testing is a powerful tool in genetic diagnosis as it allows for a comprehensive analysis of multiple genes at once, providing a more efficient and cost-effective approach compared to traditional sequencing methods. It can help in confirming a diagnosis, determining the mode of inheritance, and providing information for genetic counseling and family planning.

If an individual suspects they have DFNA6 or a healthcare provider suspects this condition based on symptoms, NGS genetic testing can be ordered to analyze the WFS1 gene and potentially identify any pathogenic variants that may be responsible for the deafness. This information can be valuable in understanding the underlying cause of the condition and guiding appropriate management and treatment options.

SKU: TEST-2696 Category:

Related products